Neuroprotective Potential of Novel Multi-Targeted Isoalloxazine Derivatives in Rodent Models of Alzheimer’s Disease Through Activation of Canonical Wnt/β-Catenin Signalling Pathway

[1]  A. Kanhed,et al.  Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis. , 2015, Bioorganic chemistry.

[2]  A. Kanhed,et al.  Neuroprotective Role of Novel Triazine Derivatives by Activating Wnt/β Catenin Signaling Pathway in Rodent Models of Alzheimer’s Disease , 2015, Molecular Neurobiology.

[3]  P. Campolongo,et al.  Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats , 2014, Front. Behav. Neurosci..

[4]  Hui Zhao,et al.  TL-2 attenuates β-amyloid induced neuronal apoptosis through the AKT/GSK-3β/β-catenin pathway. , 2014, The international journal of neuropsychopharmacology.

[5]  S. Siegelbaum,et al.  The hippocampal CA2 region is essential for social memory , 2014, Nature.

[6]  N. Inestrosa,et al.  Wnt Signaling in the Nervous System and in Alzheimer's Disease Inestrosa and Varela-nallar Inestrosa and Varela-nallar , 2022 .

[7]  K. Gupta,et al.  Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/β-catenin pathway. , 2014, ACS nano.

[8]  Stephen L. Abrams,et al.  Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention , 2013, Leukemia.

[9]  M. Ramírez,et al.  Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice. , 2013, The international journal of neuropsychopharmacology.

[10]  Di Liu,et al.  Neuroprotective Effects of Ginsenoside Rb1 on High Glucose-Induced Neurotoxicity in Primary Cultured Rat Hippocampal Neurons , 2013, PloS one.

[11]  Hai-bin Luo,et al.  Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease. , 2013, Journal of medicinal chemistry.

[12]  N. Yazıhan,et al.  The effect of intracerebroventricular injection of beta amyloid peptide (1-42) on caspase-3 activity, lipid peroxidation, nitric oxide and NOS expression in young adult and aged rat brain. , 2013, Turkish neurosurgery.

[13]  W. Weis,et al.  The β-catenin destruction complex. , 2013, Cold Spring Harbor perspectives in biology.

[14]  L. Wen,et al.  Concentration-dependent effects of fullerenol on cultured hippocampal neuron viability , 2012, International journal of nanomedicine.

[15]  C. Reitz.  Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review , 2012, International journal of Alzheimer's disease.

[16]  Si-Kwan Kim,et al.  Effect of fermented Panax ginseng extract (GINST) on oxidative stress and antioxidant activities in major organs of aged rats , 2012, Experimental Gerontology.

[17]  M. Elmlinger,et al.  Neuroprotective and Anti-Oxidative Effects of the Hemodialysate Actovegin on Primary Rat Neurons in Vitro , 2011, NeuroMolecular Medicine.

[18]  N. Inestrosa,et al.  Interactions of AChE with Aβ Aggregates in Alzheimer’s Brain: Therapeutic Relevance of IDN 5706 , 2011, Front. Mol. Neurosci..

[19]  Jerry Yang,et al.  Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: dual activity as cholinesterase and Aβ-aggregation inhibitors. , 2011, Bioorganic & medicinal chemistry.

[20]  Tao Wang,et al.  Huperzine A Activates Wnt/β-Catenin Signaling and Enhances the Nonamyloidogenic Pathway in an Alzheimer Transgenic Mouse Model , 2011, Neuropsychopharmacology.

[21]  E. Melamed,et al.  Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid β‐peptide , 2011, Journal of neurochemistry.

[22]  G. V. Chaitanya,et al.  PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration , 2010, Cell Communication and Signaling.

[23]  Hyoung‐Chun Kim,et al.  Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice. , 2010, European journal of pharmacology.

[24]  V. Cuomo,et al.  Soluble βamyloid1‐42: a critical player in producing behavioural and biochemical changes evoking depressive‐related state? , 2010, British journal of pharmacology.

[25]  F. Gunn-Moore,et al.  The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease. , 2010, The Biochemical journal.

[26]  Tracy O'Connor,et al.  Protein aggregation diseases: pathogenicity and therapeutic perspectives , 2010, Nature Reviews Drug Discovery.

[27]  N. Inestrosa,et al.  Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model of Alzheimer's disease , 2010, Molecular Psychiatry.

[28]  N. Inestrosa,et al.  Wnt signaling activation reduces neuropathological markers in a mouse model of Alzheimer's disease , 2010, Molecular Psychiatry.

[29]  M. Murphy,et al.  Alzheimer's disease and the amyloid-beta peptide. , 2010, Journal of Alzheimer's disease : JAD.

[30]  N. Inestrosa,et al.  Amyloid-β-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Aβ peptide. Implications for the pathogenesis of Alzheimer's disease , 2010, Molecular Neurodegeneration.

[31]  K. Nave,et al.  Neurod1 is essential for the survival and maturation of adult-born neurons , 2009, Nature Neuroscience.

[32]  Gene W. Yeo,et al.  Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis , 2009, Nature Neuroscience.

[33]  G. Böhm,et al.  Synthesis of Dimeric Quinazolin‐2‐one, 1,4‐Benzodiazepin‐2‐one, and Isoalloxazine Compounds as Inhibitors of Amyloid Peptides Association , 2009, Archiv der Pharmazie.

[34]  A. Paetau,et al.  Neuronal caspase-3 and PARP-1 correlate differentially with apoptosis and necrosis in ischemic human stroke , 2009, Acta Neuropathologica.

[35]  Yong Shen,et al.  Interruption of β-Catenin Signaling Reduces Neurogenesis in Alzheimer's Disease , 2009, The Journal of Neuroscience.

[36]  Paula van Tijn,et al.  Wnt signaling in Alzheimer's disease: Up or down, that is the question , 2009, Ageing Research Reviews.

[37]  M. Pákáski,et al.  Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease , 2008, Neurochemistry International.

[38]  Yumin Yang,et al.  Chitooligosaccharides protect cultured hippocampal neurons against glutamate-induced neurotoxicity , 2008, Neuroscience Letters.

[39]  Seth Love,et al.  Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial , 2008, The Lancet.

[40]  N. Inestrosa,et al.  Amyloid–cholinesterase interactions , 2008, The FEBS journal.

[41]  I. Melnikova.  Therapies for Alzheimer's disease , 2007, Nature Reviews Drug Discovery.

[42]  S. Kaech,et al.  Culturing hippocampal neurons , 2006, Nature Protocols.

[43]  F. LaFerla,et al.  Pathways by which Abeta facilitates tau pathology. , 2006, Current Alzheimer research.

[44]  Johannes Kornhuber,et al.  Therapeutic approaches to Alzheimer's disease. , 2006, Brain : a journal of neurology.

[45]  B. Rozman,et al.  Immunohistochemical expression of activated caspase-3 as a marker of apoptosis in glomeruli of human lupus nephritis. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  Dong Hee Lee,et al.  Induction of apoptosis by disturbing mitochondrial-membrane potential and cleaving PARP in Jurkat T cells through treatment with acetoxyscirpenol mycotoxins. , 2006, Biological & pharmaceutical bulletin.

[47]  Thuy-vi Nguyen,et al.  β-Amyloid-Induced Neuronal Apoptosis Involves c-Jun N-Terminal Kinase-Dependent Downregulation of Bcl-w , 2005, The Journal of Neuroscience.

[48]  N. Inestrosa,et al.  The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from β-amyloid neurotoxicity by acting on Wnt signaling components , 2005, Neurobiology of Disease.

[49]  A. Adamczyk,et al.  Alzheimer's disease related peptides affected cholinergic receptor mediated poly(ADP-ribose) polymerase activity in the hippocampus. , 2005, Folia neuropathologica.

[50]  Miguel Bronfman,et al.  Signal transduction during amyloid-β-peptide neurotoxicity: role in Alzheimer disease , 2004, Brain Research Reviews.

[51]  D. Dickson.  Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect? , 2004, The Journal of clinical investigation.

[52]  Li Di,et al.  High throughput artificial membrane permeability assay for blood-brain barrier. , 2003, European journal of medicinal chemistry.

[53]  C. Geula,et al.  Neurobiology of butyrylcholinesterase , 2003, Nature Reviews Neuroscience.

[54]  N. Inestrosa,et al.  Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by β-amyloid fibrils , 2003, Molecular Psychiatry.

[55]  M. Greicius,et al.  Regional analysis of hippocampal activation during memory encoding and retrieval: fMRI study , 2003, Hippocampus.

[56]  N. Inestrosa,et al.  Protein kinase C inhibits amyloid β‐peptide neurotoxicity by acting on members of the Wnt pathway , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  W. Friedman,et al.  Mechanisms of p75-mediated Death of Hippocampal Neurons , 2002, The Journal of Biological Chemistry.

[58]  D. Butterfield.  Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. , 2002, Free radical research.

[59]  K. Mielke,et al.  Caspase-3 activation and DNA fragmentation in primary hippocampal neurons following glutamate excitotoxicity. , 2001, Brain research. Molecular brain research.

[60]  K. Roth.  Caspases, Apoptosis, and Alzheimer Disease: Causation, Correlation, and Confusion , 2001, Journal of neuropathology and experimental neurology.

[61]  R. D'Hooge,et al.  Applications of the Morris water maze in the study of learning and memory , 2001, Brain Research Reviews.

[62]  H. Suh,et al.  Protection against β‐amyloid peptide toxicity in vivo with long‐term administration of ferulic acid , 2001, British journal of pharmacology.

[63]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[64]  B Testa,et al.  Predicting blood-brain barrier permeation from three-dimensional molecular structure. , 2000, Journal of medicinal chemistry.

[65]  J. Strosznajder,et al.  Effect of amyloid beta peptide on poly(ADP-ribose) polymerase activity in adult and aged rat hippocampus. , 2000, Acta biochimica Polonica.

[66]  G. de Murcia,et al.  Importance of Poly(ADP-ribose) Polymerase and Its Cleavage in Apoptosis , 1998, The Journal of Biological Chemistry.

[67]  K. Davis.  Cholinesterase Inhibitors in Alzheimer's Disease , 1994, Neuropsychopharmacology.

[68]  N. Berger.  Poly(ADP-ribose) in the cellular response to DNA damage. , 1985, Radiation research.

[69]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.